Tech Company Financing Transactions
OnTarget Laboratories Funding Round
OnTarget Laboratories, based in Northbrook, scored $30 million from H.I.G. Capital, 3B Future Health Fund and Elevate Ventures.
Transaction Overview
Company Name
Announced On
11/16/2023
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series C
Investors
Proceeds Purpose
This investment empowers us to accelerate the commercialization of our novel technology, further solidifying our position at the forefront of intraoperative molecular imaging," said Ben Lundgren, President and CEO of On Target Laboratories.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
4065 Commercial Ave.
Northbrook, IL 60062
USA
Northbrook, IL 60062
USA
Phone
Website
Email Address
Not Recorded
Overview
On Target's technology is based on the work done by Dr. Philip S. Low; the Ralph C. Corley distinguished professor of chemistry at Purdue University. A major focus in his lab has been the discovery and development of small molecules that target specific pathological cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Martin Low
Browse more venture capital transactions:
Prev: 11/16/2023: Quoherent venture capital transaction
Next: 11/16/2023: Revolv venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs